Literature DB >> 8053734

Current management of carcinoma of the breast.

T J Eberlein1.   

Abstract

OBJECTIVE: An in-depth retrospective review of the multidisciplinary approach to the management of carcinoma of the breast was done. The author reviewed previous trials and treatment from the past to the present. The indications and contraindications of surgical procedures, radiation therapy, systemic chemotherapy, and hormonal therapy are discussed. SUMMARY BACKGROUND DATA: Carcinoma of the breast is one of the most common malignancies treated by the practicing general or oncologic surgeon. The disease is best treated using a multidisciplinary approach, combining the efforts of surgery, radiation therapy, and systemic treatments. Understanding the indications and contraindications for each of these modalities will provide the practicing surgeon the most up-to-date algorithms for the management of his/her patient.
CONCLUSIONS: The author provides a comprehensive analysis of the multidisciplinary approach to the management of carcinoma of the breast. It emphasizes the results of previous trials and discusses future controversies and areas for study.

Entities:  

Mesh:

Year:  1994        PMID: 8053734      PMCID: PMC1234351          DOI: 10.1097/00000658-199408000-00003

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  125 in total

1.  Breast implants--protection or paternalism?

Authors:  M Angell
Journal:  N Engl J Med       Date:  1992-06-18       Impact factor: 91.245

2.  Optimal mastectomy timing.

Authors:  W L McGuire; S Hilsenbeck; G M Clark
Journal:  J Natl Cancer Inst       Date:  1992-03-04       Impact factor: 13.506

3.  A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.

Authors:  P R Rosen; S Groshen; P E Saigo; D W Kinne; S Hellman
Journal:  J Clin Oncol       Date:  1989-03       Impact factor: 44.544

4.  Breast-conserving surgery and definitive radiation: a comparison between quadrantectomy and local excision with special focus on local-regional control and cosmesis.

Authors:  M A Fagundes; H M Fagundes; C S Brito; M H Fagundes; A Daudt; L A Bruno; S J Azevedo; L A Fagundes
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-10-20       Impact factor: 7.038

5.  Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.

Authors:  C Escot; C Theillet; R Lidereau; F Spyratos; M H Champeme; J Gest; R Callahan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

Review 6.  Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy.

Authors:  M S Anscher; P Jones; L R Prosnitz; W Blackstock; M Hebert; R Reddick; A Tucker; R Dodge; G Leight; J D Iglehart
Journal:  Ann Surg       Date:  1993-07       Impact factor: 12.969

7.  Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy.

Authors:  L E Rutqvist; B Cedermark; U Glas; A Mattsson; L Skoog; A Somell; T Theve; N Wilking; J Askergren; M L Hjalmar
Journal:  J Natl Cancer Inst       Date:  1991-09-18       Impact factor: 13.506

8.  Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study.

Authors:  S A Bartow; D R Pathak; W C Black; C R Key; S R Teaf
Journal:  Cancer       Date:  1987-12-01       Impact factor: 6.860

Review 9.  Clinical decision-making in early breast cancer.

Authors:  C M Balch; S E Singletary; K I Bland
Journal:  Ann Surg       Date:  1993-03       Impact factor: 12.969

10.  Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer.

Authors:  S Paik; R Hazan; E R Fisher; R E Sass; B Fisher; C Redmond; J Schlessinger; M E Lippman; C R King
Journal:  J Clin Oncol       Date:  1990-01       Impact factor: 44.544

View more
  3 in total

1.  Treatment of breast cancer.

Authors:  R A Evans
Journal:  Ann Surg       Date:  1995-04       Impact factor: 12.969

2.  Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model.

Authors:  C L Addison; T Braciak; R Ralston; W J Muller; J Gauldie; F L Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

3.  Considering the Relationship between Quantitative Parameters and Prognostic Factors in Breast Cancer: Can Mean Standardized Uptake Value be an Alternative to Maximum Standardized Uptake Value?

Authors:  Reyhan Köroğlu; İsmail Köksal; Fikri Selçuk Şimşek; Fatma Gezer; Ersoy Kekilli; Bülent Ünal
Journal:  World J Nucl Med       Date:  2017 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.